| CANINE HYPOTHYROIDISM |
Signalment
Hypothyroidism is common endocrine disease of dogs that can affect both
males and females of nearly any age although it is rare in dogs less than
two years old.
Pathophysiology
Hypothyroidism is invariably primary (i.e. disease of the thyroid gland
itself) and is usually caused by either lymphocytic thyroiditis or idiopathic
atrophy. As the disease progresses the ability of the thyroid gland to secrete
the principal thyroid hormone T4 decreases
and clinical signs develop. T4 normally
inhibits the secretion of cTSH from the pituitary gland by a negative feedback
mechanism. In primary hypothyroidism this feedback is lost and cTSH concentrations
increase.
|
| CLINICAL SIGNS |
| The most common clinical features of hypothyroidism
include: |
| * |
Lethargy |
| * |
Weight gain |
| * |
Dermatological signs including hair loss, pyoderma, scaling
& scurfing |
| * |
Neurological signs e.g. facial nerve neuropathy |
| * |
Exercise intolerance and weakness |
Diagnostic Tests
Combined measurement of total T4 and cTSH concentrations (standard profile)
provide an inexpensive and accurate method of confirming or excluding
hypothyroidism. Further improvement in diagnostic accuracy is obtained by
concurrent estimation of free T4 measured by dialysis (premium profile).
Free T4 is the metabolically active portion of T4 and most accurately reflects
tissue thyroid status. Note that the old analogue method for free T4 measurement
is now known to offer no advantage over total T4 measurement. If free T4
measurement is being offered, always enquire as to whether a dialysis method
is being used. Recent research has demonstrated that the presence of circulating
thyroglobulin autoantibodies is very strong evidence for the presence of
thyroid pathology. The comprehensive profile includes these antibodies in
the test panel and therefore provides maximal information regarding thyroidal
status. Dynamic tests of thyroid function are also available. If you are
considering performing one of these tests, we recommend that you contact
the laboratory to discuss this in advance.
Monitoring Tests
Most dogs can be well controlled with once daily thyroid hormone supplementation.
Twice daily therapy is rarely required. When monitoring therapy, the time
of sampling relative to thyroid hormone administration has a profound influence
on the hormone concentrations that are obtained. It is therefore recommended
that samples collected for monitoring profiles should be collected six hours
post-pill, for total T4 and cTSH estimation. Monitoring profiles can be
performed within approximately 7-14 days of starting treatment or changing
the dosage. Well treated dogs usually have peak total T4 values approximately
50-70 nmol/L and cTSH concentration near the assay limit of detection (0.01-0.03
nglml).
Sample Requirements |
| * |
Standard profile (T4, cTSH) |
1-2 ml serum (clotted) |
| * |
Premium profile (T4, cTSH, fT4d) |
1-2 ml serum (clotted) |
| * |
Comprehensive profile (T4, cTSH, fT4d, TgAb) |
1-2 ml serum (clotted) |
| * |
Monitoring profile (T4, cTSH) (6 hours post-pill) |
1-2 ml serum (clotted) |
Points to Note:
Various therapies will influence thyroid test results. Ideally dogs should
not have received these for a minimum of six weeks prior to sampling. If
testing cannot be delayed, please ensure that the relevant drug therapies
are noted on the submission form as these drugs will alter the results obtained.
The most important drugs to try and avoid are: |
| * |
Steroids |
| * |
Anticonvulsants |
| * |
Sulphonamides |
| * |
Thyroid hormone replacement (unless monitoring treatment
of course !) |
|
back
to top of the page |
| CANINE HYPERADRENOCORTICISM |
Signalment
Hyperadrenocorticism (HAC) usually occurs in middle aged or old dogs.
Predisposed breeds include poodles, small terriers (e.g. Border and Yorkshire
terriers) and daschunds. Both males and females can be affected.
Pathophysiology
HAC results from excess production of glucocorticoids by the adrenal cortices.
This is usually caused by excessive ACTH secretion from the pituitary gland
pituitary dependant hyperadrenocorticism (PDH). PDH is most commonly
caused by an adenoma the pars intermedia of the pituitary gland and accounts
for approximately 80 % of all cases of HAC. The remaining 20 % of HAC cases
result from excessive glucocorticoid secretion by a functioning adrenal
tumour (AT) (either an adenoma or a carcinoma, both of which occur with
approximately equal frequency).
|
| CLINICAL SIGNS |
| The most common clinical features of HAC include: |
| * |
Polyuria |
| * |
Polydipsia |
| * |
Weight loss |
| * |
Abdominal enlargement |
| * |
Calcinosis cutis |
| * |
Poor exercise tolerance |
| * |
Endocrine alopecia |
| * |
Polyphagia |
| * |
Muscle weakness |
| * |
Skin thinning |
| * |
Panting and restlessness |
| * |
Neurological signs referable to a pituitary mass |
|
Diagnostic Tests
It is important to recognise that there is no perfect
test for HAC. Consequently, it is particularly important that tests of adrenal
status are interpreted with a strong bearing ultimately being placed on
your own clinical judgement. For this reason please provide as much clinical
information as possible when submitting samples for the confirmation of
HAC.
In the dexamethasone suppression test, cortisol is estimated
before and after exogenous dexamethasone administration. In healthy dogs,
the dexamethasone has a negative feedback effect on the pituitary gland
and inhibits ACTH secretion. This reduces endogenous cortisol production
by the adrenal cortices and consequently post dexamethasone cortisol concentrations
are suppressed. However, in dogs with PDH, the pituitary gland is secreting
large quantities of ACTH autonomously and is not responsive to the negative
feedback effect of dexamethasone. Similarly, in dogs with AT, the secretion
of cortisol by the neoplastic adrenocortical cells is independent of ACTH.
Thus, in dogs with HAC caused by either PDH or AT, the cortisol concentration
does not decrease significantly after dexamethasone administration. The
dexamethasone suppression test is a good screening test for HAC, but can
give false positive results. The most reliable method of minimising these
false positive results, is to (as far as possible) avoid stressing
patients during the test, and to judiciously select patients to test based
on their clinical signs, routine biochemical and haematological changes,
and the prior exclusion of other possible diseases.
In the ACTH stimulation test blood samples are collected
for cortisol estimation before and after exogenous ACTH administration.
The dose of ACTH given is supraphysiological and consequently the cortisol
response to ACTH is essentially dependant upon the number of functioning
adrenocortical cells. The test can therefore be considered to be an assessment
of adrenal size. Since there is an increase in adrenal
tissue in both PDH (which causes bilateral adrenal hyperplasia) and AT,
an exaggerated cortisol response to ACTH usually occurs in dogs with HAC
irrespective of the cause. Post-ACTH cortisol values greater than 600 nmol/L
support a clinical diagnosis of HAC. The ACTH stimulation test can give
false negative results and so dont completely rule out the possibility
of HAC because of a normal ACTH stimulation test, if you remain strongly
clinically suspicious of the disease.
Monitoring Tests
When monitoring therapy for HAC, the ACTH stimulation test is the test of
choice. A well controlled dog should have pre and post-ACTH cortisol concentrations
in the region of 50 nmol/L.
The determination of the Urinary Cortisol to Creatinine
Ratio (UCCR) can be used as a screening test for HAC. The UCCR is
unable to definitively confirm HAC since non-adrenal disease can also give
positive results, but the test can quite confidently rule out HAC as a possible
diagnosis, helping in the overall final patient assessment. Since the secretion
of cortisol (even in dogs with HAC) tends to be quite episodic, the
estimation of average blood cortisol secretion would
be a useful marker of adrenal status. Since cortisol is excreted in the
urine, this can be achieved by measurement of urine cortisol concentration.
Compensation for variable rates of glomerular filtration is achieved by
determination of the UCCR. A UCCR less than 10 rules out the possibility
of HAC. A UCCR more than 70 is consistent with HAC and warrants more specific
testing such as the dexamethasone suppression or ACTH stimulation tests.
Differentiating PDH from AT
Endogenous ACTH measurement can be used to differentiate PDH (in which
the ACTH concentration is usually elevated) from AT (in which the
ACTH concentration is usually depressed). Samples must be collected
using a strict protocol outlined below.
Sample Requirements
In the ACTH stimulation test clotted blood samples are collected for cortisol
estimation immediately before and one hour after intramuscular administration
of 250 pg soluble exogenous ACTH. In the dexamethasone suppression test
clotted blood samples are collected for cortisol estimation immediately
before, and three and eight hours after the intravenous administration of
0.015 mg/kg dexamethasone. For both tests 1 ml serum is required per sample.
For the urinary cortisol:creatinine ratio, an overnight urine sample should
be collected at approximately gam at home.
In cats the ACTH should be given intravenously. Basal samples together with
samples at 60 minutes and 90 or 120 minutes should be collected. This is
not a reliable test in the cat and the HDDST is recommended. 0.1mg/kg dexamethasone
is given i/v and samples collected at time 0 4 and 8 hrs.
Endogenous ACTH is very labile and consequently strict sample handling procedures
must be followed. Collect blood into a chilled plastic (not glass) tube
containing EDTA as the anticoagulant. Gently mix and then immediately centrifuge
for 3-5 minutes. Immediately decant the plasma into a chilled plain plastic
(not glass) tube and freeze. Transport the sample frozen on ice for
ACTH estimation.
Points to Note:
Try and avoid patient stress as much as possible during these tests. In
particular, do not collect urine for the UCCR in a hospital environment
as the stress of hospitalisation can in itself lead to false positive results.
Instead, have the sample collected from the dog by the owner in the home
environment.
Steroid therapy will interfere with both normal adrenal
physiology and assays for cortisol estimation. If in doubt about which test
to use in this situation, please contact the laboratory for specific advice. |
back
to top of the page |
| HYPERTHYROIDISM |
Signalment
Hyperthyroidism is a very common disease of older cats. It is rare in cats
less than seven years. All breeds and types of cats may be affected but
Siamese are under?represented. Hyperthyroidism has been increasingly recognised
in dogs over the past five years, but it remains a rare disease in this
species.
Pathophysiology Feline hyperthyroidism almost always results
from excessive secretion of T4 caused by benign adenomatous hyperplasia
usually affecting both thyroid lobes. Canine hyperthyroidism is usually
caused by a functional thyroid carcinoma. |
| CLINICAL SIGNS |
| The most common clinical features associated with hyperthyroidism
are: |
| * |
Weight loss |
| * |
Polyphagia |
| * |
Polyuria |
| * |
Polydipsia |
| * |
Tachycardia |
| * |
Vomiting |
| * |
Cardiorespiratory disease |
| * |
Poor coat condition |
| * |
Hyperactivity |
|
Diagnostic Tests
Confirmation of hyperthyroidism is usually achieved by measurement of total
T4 in a serum sample. In equivocal cases, with borderline total T4 values,
dynamic tests such as the T3 suppression test can be used. However, the
recommended approach in such cases is usually to wait and re-test total
T4 about four weeks later. This usually clarifies thyroid status.
Monitoring Tests
Monitoring therapy for hyperthyroidism relies upon demonstration of a normalisation
of thyroid hormone concentrations. It is generally desirable to decrease
total T4 values to approximately 15-30 nmol/L to maintain optimal clinical
control. latrogenic hypothyroidism very rarely occurs as a complication
of therapy, and certainly it is much more common for cats to be inadequately
treated than to be over-treated.
Sample Requirements
Serum (clotted blood) is required for
total T4 estimation and this is the test of choice for both confirming the
diagnosis, and monitoring therapy. |
| DIABETES MELLITUS |
Signalment
There are multiple underlying factors that may contribute to the development
of diabetes mellitus (DM) in dogs and cats. Consequently, nearly
any age or breed may be affected. However, DM occurs most commonly in middle
aged dogs, and crossbreeds, cairn terriers, English setters, poodles and
rottweilers have been reported to be over-represented.
Pathophysiology
The causes and contributors to a state of DM are numerous and a detailed
review is beyond the scope of this manual. As a generalisation, the most
common causes of DM produce a relative or absolute deficiency of insulin
through combinations of reduced insulin production and/or decreased peripheral
insulin sensitivity. Common specific causes include autoimmune pancreatic
islet cell destruction, increased concentrations of endogenous or exogenous
glucocorticoids, and increased circulating progesterone and growth hormone
concentrations associated with metoestrus. |
| CLINICAL SIGNS |
| The most common clinical signs of DM include: |
| * |
Polyuria |
| * |
Polydipsia |
| * |
Polyphagia |
| * |
Recurring infections |
| * |
Exercise intolerance |
| * |
Cataracts |
| * |
Weight Loss |
|
Diagnostic Tests
Demonstration of concurrent glucosuria and persistent fasting hyperglycaemia
is confirmatory of DM. Transient hyperglycaemia caused by stress and other
illnesses can complicate the diagnosis of DM, particularly in cats. Broadly
speaking demonstration of a fasting blood glucose concentration greater
than 14 nmol/L (dogs) or 20 nmol/L (cats) is highly suspicious
of DM, but if confirmation of glycaemic control is required, fructosamine
estimation can be performed. Fructosamine is a glycated protein the concentration
of which reflects the average blood glucose concentration
over the previous 2-3 weeks. Markedly increased fructosamine concentrations
are confirmatory of DM.
Monitoring Tests
If monitoring is being performed with blood glucose estimation, blood samples
should be collected six hours after insulin jadministration to determine
the nadir (lowest) blood glucose concentration. However, monitoring
therapy of diabetic patients can be complicated, particularly in cats in
which stress hyperglycaemia makes routine blood glucose measurement problematic.
The clinical assessment of diabetic stability is therefore of paramount
importance. In addition to blood and urine glucose measurement, routine
estimation of blood fructosamine concentration can be used to improve evaluation
of glycaemic control.
A decrease in fructosamine values towards normal is generally consistent
with an improvement in glycaemic control, whilst an increase suggests a
worsening of diabetic control.
Sample Requirments
Blood glucose can be performed on whole blood collected into fluoride anticoagulant
tubes. Fructosamine measurement can be performed on a heparinised blood
sample.
Points to Note:
Note that falsely decreased urine glucose results can be obtained if standard
dip-stick methods for glucose estimation are used in patients receiving
vitamin C supplements.
Blood glucose cannot be measured on heparinised or EDTA samples sent through
the post. If blood is taken into these tubes by mistake, immediately centrifuge
the samples and separate the plasma before sending off for analysis. Wait
2-3 weeks after instituting or changing therapy before evaluating control
with fructosamine measurements. |
back
to top of the page |
| HYPOADRENOCORTICISM |
Signalment
Hypoadrenocorticism occurs in most large breed dogs, but a particular predisposition
has been reported in bearded collies, spaniels and standard poodles. It
is most commonly a disease of young animals, typically aged around 3-4 years.
However, it has been reported in dogs as young as three months and as old
as 14 years.
Pathophysiology
The normal adrenal cortex consists of three layers, the zona glomerulosa,
zona fasiculata, and zona reticularis. The first of these secretes mainly
mineralocoricoids, the most important of which is aldosterone, whilst the
latter two layers synthesise and secrete mainly glucocorticoids, the most
important of which is cortisol. Spontaneous hypoadrenocorticism is usually
caused by immune mediated destruction of the adrenal cortex. This usually
affects all three cortical zones and consequently there is failure of both
glucocorticoid and mineralocorticoid secretion. Failure to synthesis mineralocorticoids
and glucocorticoids can have profound, frequently fatal consequences, reducing
the ability to maintain electrolyte homeostasis and respond to stressful
stimuli.
Clirllcal Signs
Because the adrenal cortices are destroyed progressively over a period of
months or years, the clinical signs of hypoadrenocorticism can be vague
and often intermittent. However, dogs can also present acutely in an Addisonian
crisis. |
| THE MOST COMMON CLINICAL FEATURES OF HYPOADRENOCORTICISM
INCLUDE: |
| Chronic Presentation |
| * |
Waxing and waning history |
| * |
Vomiting |
| * |
Diarrhoea |
| * |
Polydipsia |
| * |
Intermittent anorexia |
| * |
Lethargy |
| * |
Weaknes |
|
| Acute Presentation |
| * |
Collapse |
| * |
Hypovolaemia |
| * |
Vomiting |
| * |
Diarrhoea |
| * |
Bradycardia |
| * |
Hypothermia |
|
Diagnostic Tests
The identification of hyperkalaemia and hyponatraemia is useful in supporting
a diagnosis of hypoadrenocorticism. These are routinely measured on heparinised
samples. Other routine abnormalities that may be encountered in dogs with
Addisons disease include hypercalcaemia, mild normochromic normocytic non-regenerative
anaemia, lymphocytosis and eosinophilia. Particularly in dogs with an acute
crisis, increased urea and creatinine are common due to profound hypovolaemic
pre-renal azotaemia. Confirmation of hypoadrenocorticism is readily achieved
with an ACTH stimulation test. Failure of cortisol to significantly increase
confirms a lack of functioning adrenocortical cells and supports a diagnosis
of hypoadrenocorticism.
Monitoring Tests
Biochemical therapeutic monitoring of hypoadrenocorticism relies largely
on electrolyte (Na & K) estimation.
Sample Requirements
Heparinised blood is suitable for the routine electrolytes. Note that separation
of the plasma prior to sending to the laboratory is recommended to help
accurately determine electrolyte concentrations. For the ACTH stimulation
test, whole blood (clotted) should be collected immediately before
and one hour after the intramuscular administration of 250 pg synthetic
ACTH.
Points to Note:
Most steroids used in veterinary practice cross?react with cortisol assays
and if administered prior to or during an ACTH stimulation test, will give
inaccurate cortisol results. Dexamethasone does not cross react in this
way and can be used in the emergency situation for patients who needs urgent
glucocorticoid replacement whilst the ACTH stimulation test is being performed. |
back
to top of the page |
| Summary of Endocrine Protocols for Quick Reference |
| ADRENAL FUNCTION |
| Test |
Uses |
Protocol |
ACTH stimulation test
(dogs and cats) |
Confirming spontaneous HAC |
Collect fasted clotted blood sample (0 hour). Confirming
iatrogenic HAC Administer 250 mg synthetic ACTH intramuscularly. Confirming
hypoadrenocorticism Collect second whole blood sample one hour later
Monitoring therapy for HAC In cats administer 125 mg ACTH intramuscularly
and collect samples at 0.1 and 2 hours. |
Dexamethasone suppression test
(dogs and cats) |
Confirming spontaneous HAC |
Collect fasted clotted blood sample (0 hour)
Administer 0.015 mg/kg dexamethasone
intravenously. Collect clotted blood 3 and 8 hours after dexamethasone.
In cats administer 0.1 mg/kg dexamethasone and collect samples
at 0.4 and 8hours. |
Urinary cortisol : creatinine ratio
(dogs & horses) |
Screening test for spontaneous HAC |
Collect morning urine sample from patient in normal home environment. |
| Endogenous ACTH estimation (dogs) |
Differentiating PHD from AT |
Collecting blood sample into a chilled plastic (not glass)
tube containing EDTA.
Spin sample, decant into PLAIN plastic
(not glass) and freeze plasma immediately. Transport plasma
samples frozen on ice in plain tubes. |
Dexamethasone suppression test
(day 1) ( horses) |
Confirming HAC |
Collecting whole blood at approximately 5pm. Administer 40
ug/ml dexamethasone intra muscularly. Collect second whole blood sample
19 hours later (approximately 11am,
day 2). |
| TRH response test (horses) |
Confirming HAC |
Collect clotted blood sample (perform test in the
morning). Administer 1 mg TRH intravenously (slowly over approximately
one minute). Collect whole blood samples at 0, 30 and 60
minutes. |
| Combined ACTH stimulation /dexamethasone
suppression test (cats) |
Screening test for HAC |
Collect blood sample then administer 0.1 mg/kg dexamethasone.
Collect second clotted sample after two hours and immediately
administer 125 mg ACTH i.v. Collect clotted blood sample one hour
later |
|
back
to top of the page |
| THYROID FUNCTION |
| Test |
Uses |
Protocol |
Standard/monitoring profile
(dogs: TT4 & cTSH) |
Confirming canine hypothyroidism Monitoring canine
hypothyroidism |
Collect clotted blood sample
For monitoring canine thyroid hormone
therapy. |
| (cats: TT4) |
Confirming or monitoring hyperthyroidism |
Collect sample six hours post-pill |
Premium profile
(TT4 cTSH & fT4d) |
Confirming canine hypothyroidism |
Collect clotted blood sample |
| Comprehensive profile (TT4
cTSH fT4d & TgAb) |
Confirming canine hypothyroidism |
Collect clotted blood sample |
| TSH stimulation test (dogs) |
Confirming hypothyroidism |
Collect clotted blood sample (0 hours) Administer 0.1
iu bovine TSH intravenously
Collect second whole blood sample six hours later (note this product
is NOT licensed for this use). |
TRH stimulation test 1
(dogs) |
Evaluating pituitary function |
Collect clotted blood sample (0 minutes)
Administer 10 mg/kg TRH intravenously. Collect clotted blood at
20 & 30 minutes post TRH |
TRH stimulation test 2
(dogs) |
Ruling out hypothyroidism |
Collect whole blood sample (0 hours)
Administer 200 mg TRH intravenously. Collect whole blood sample
four hours later |
TSH stimulation
(horses) |
Evaluating thyroid function |
Collect clotted blood sample (0 hours)
Administer 5 i.u. TSH intramuscularly.
Collect second clotted sample six hours later |
T3 suppression test
(cats) |
Diagnosis of equivocal hyperthyroidism. (note
this test is not routinely recommended) |
Collect clotted blood sample
Administer 20 mg T3 TID for seven doses
Collect whole blood three hours after last T3
dose |
|
back
to top of the page |
| Miscellaneous
Endocrine Protocols |
| Test |
Uses |
Protocol |
| Fructosamine & Glucose |
Used in diabetic patients to monitor the adequacy of therapy. |
Collect blood 6 hours post-insulin administration for the
glucose (fluoride) and fructosamine (heparin)
estimation. |
| Insulin |
Diagnosis of insulinoma (dogs) or HAC (horses). |
Collect clotted blood and immediately centrifuge and separate
the serum from the red cells.
Freeze the serum and transport chilled/on ice. |
| Parathyroid function |
Evaluation of hypercalcaemia Evaluation of hypocalcaemia |
Collect clotted blood and immediately centrifuge and separate
the serum from the red cells. Freeze the serum and transport frozen on ice. |
| HAC |
Hyperadrenocorticism |
TSH |
Thyrotropin (thyroid stimulating hormone) |
| PDH |
Pituitary dependant hyperadrenocorticism |
cTSH |
Canine thyrotropin |
| AT |
Hyperadrenocorticism caused by an adrenal tumour |
TgAb |
Thyroglobulin autoantibodies |
| TT4 |
Total thyroxine |
T3 |
Triiodothyronine |
| FT4d |
Free thyroxine (measured by dialysis) |
TRH |
Thyrotropin releasing hormone |
|
| Reproductive
Endocrinology |
| CRYPTORCHIDISM |
This test is based on the measurement of dynamic (pre and
post HCG) Testosterone. In the horse the following protocol
is advised: |
| * |
Take basal serum or heparinised plasma samples, inject 6000
iu HCG I.V. |
| * |
Collect a second sample between 30 mins-2 hours post injection,
noting the time taken on the post sample. |
| * |
A modified HCG test can be used in the dog and the cat, the
protocol is the same except, only 750 iu HCG is used in the dog and 500
iu HCG in cats. |
| * |
If testicular tissue is present then a significant rise in
testosterone is detected post stimulation. |
| * |
Single sample Oestrone sulphate tests may be used in horses
over 3 years of age, but are not of any value under this age and cannot
be used in donkeys. This laboratory recommends the dynamic Testosterone
test in most cases. |
|
back
to top of the page |
| IDENTIFICATION OF OVARIAN REMNANTS IN THE CAT |
| This test is based on the measurement of dynamic (pre and
post HCG) progesterone. In the cat the following protocol is advised: |
| * |
Take basal serum or heparinised plasma samples, inject 500
iu HCG I.V. |
| * |
Collect a second sample as above seven days later |
| * |
If ovarian tissue is present then a significant rise in progesterone
is detected post stimulation. |
| DYNAMIC TESTING FOR ADRENAL SEX HORMONE PRODUCTION |
| The protocols for this are undergoing constant change. As
such it is advisable to telephone the laboratory prior to any testing to
discuss the current protocols. |
| OVULATION DETECTION IN BITCHES |
| * |
This involves sequential heparinised plasma or serum samples
for progesterone. |
| * |
As the values vary slightly between plasma and serum, it is
advised that either sample is used, but not mixed, i.e., do not use a plasma
sample, followed two days later by a serum sample. |
| * |
Most bitches ovulate on day 13 of the cycle, it is recommended
that basal levels are established on days 9-10, then the lab will advise
on when the next sample should be taken, based on the following :­ |
| <6 nmol/L |
NOT OVULATED |
| 6-10 nmol/L |
OVULATED MATE WITHIN 72 HOURS |
| 10-20 nmol/L |
OVULATED MATE WITHIN 48 HOURS |
| 20-32 nmol/L |
OVULATED MATE WITHIN 24 HOURS |
| 32 nmol/L |
TOO LATE |
| * |
It is wise to note that these values are usually reported
24 hours post sampling and those 24 hours need to be taken off the above
times, i.e. the above times relate to the time of sampling. |
|
| PREGNANCY TESTING |
In equine serum PMSG levels can be measured for pregnancy
between days 45-90. The production of PMSG is biologically variable and
it is better to sample between these dates e.g. around 60 days, rather than
at either end of the range.
Oestrone sulphate will be present at approximately day
70 and in significant amounts between days 110 & 240. It is present
until the end of pregnancy but values fall in the last 4-6 weeks and interpretation
can be difficult in this period. The cow and pig have raised oestrone sulphate
levels at certain periods through pregnancy. It is advisable to therefore
contact the lab first to discuss.
Recently a test for serum Relaxin concentration has been
validated for confirming pregnancy in bitches. This test is available at
Axiom Veterinary Laboratories. Pregnancy can be confirmed from day 21 using
this method. Single progesterone values have been used in the horse and
cow, at the predicted return to oestrus dates, to indicate possible early
pregnancy. They are not specific indicators of pregnancy, just indicators
of luteal activity, from which assumptions are made. |
back to top of the page
|